P.S. Mitrou

754 total citations
40 papers, 541 citations indexed

About

P.S. Mitrou is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, P.S. Mitrou has authored 40 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in P.S. Mitrou's work include Acute Myeloid Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Lymphoblastic Leukemia research (5 papers). P.S. Mitrou is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Lymphoblastic Leukemia research (5 papers). P.S. Mitrou collaborates with scholars based in Germany, United Kingdom and Romania. P.S. Mitrou's co-authors include D. Hoelzer, Lothar Bergmann, Eckhart Weidmann, Jürgen Brieger, Klaus Fenchel, Bernhard Jahn, Ulrich Maurer, Simone Boehrer, Kai Uwe Chow and Lars Bergmann and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Leukemia.

In The Last Decade

P.S. Mitrou

38 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.S. Mitrou Germany 11 257 161 147 133 117 40 541
Susan R. Wiersma United States 13 137 0.5× 260 1.6× 78 0.5× 175 1.3× 75 0.6× 16 517
Metter Ge United States 9 93 0.4× 189 1.2× 261 1.8× 78 0.6× 59 0.5× 13 538
CM Niemeyer United States 9 151 0.6× 346 2.1× 114 0.8× 248 1.9× 136 1.2× 15 631
Anna Grazia Recchia Italy 16 265 1.0× 302 1.9× 166 1.1× 154 1.2× 151 1.3× 38 653
D Hollard France 13 102 0.4× 432 2.7× 118 0.8× 117 0.9× 185 1.6× 56 612
Bloomfield Cd United States 12 101 0.4× 220 1.4× 110 0.7× 129 1.0× 76 0.6× 23 416
R. Schlenk Germany 10 183 0.7× 473 2.9× 96 0.7× 180 1.4× 139 1.2× 20 629
Hai‐Rong Qiu China 13 171 0.7× 216 1.3× 150 1.0× 60 0.5× 211 1.8× 60 498
Laurence Detourmignies France 9 195 0.8× 237 1.5× 100 0.7× 86 0.6× 70 0.6× 16 402
Angeline Van Orshoven Belgium 15 183 0.7× 488 3.0× 75 0.5× 152 1.1× 291 2.5× 29 735

Countries citing papers authored by P.S. Mitrou

Since Specialization
Citations

This map shows the geographic impact of P.S. Mitrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.S. Mitrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.S. Mitrou more than expected).

Fields of papers citing papers by P.S. Mitrou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.S. Mitrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.S. Mitrou. The network helps show where P.S. Mitrou may publish in the future.

Co-authorship network of co-authors of P.S. Mitrou

This figure shows the co-authorship network connecting the top 25 collaborators of P.S. Mitrou. A scholar is included among the top collaborators of P.S. Mitrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.S. Mitrou. P.S. Mitrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Pierce K. H., Daniel Nowak, Sang Wook Kim, et al.. (2005). In vivo drug-response in patients with leukemic non-Hodgkin's lymphomas is associated with in vitro chemosensitivity and gene expression profiling. Pharmacological Research. 53(1). 49–61. 13 indexed citations
2.
Boehrer, Simone, Daniel Nowak, Seung Wook Kim, et al.. (2005). Expression of Daxx sensitizes Jurkat T-cells to the apoptosis-inducing effect of chemotherapeutic agents. Pharmacological Research. 51(4). 367–374. 4 indexed citations
3.
Weidmann, Eckhart, Martin Gramatzki, Mathias Wilhelm, & P.S. Mitrou. (2004). Diagnosis and actual therapy strategies in peripheral T-cell lymphomas: summary of an international meeting. Annals of Oncology. 15(3). 369–374. 3 indexed citations
4.
Chow, Kai Uwe, et al.. (2001). In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.. PubMed. 86(5). 485–93. 57 indexed citations
5.
Weidmann, Eckhart, Jürgen Brieger, T. Karakas, et al.. (1997). Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501. Leukemia. 11(5). 709–713. 2 indexed citations
6.
Vogt, Hans‐Georg, et al.. (1996). Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.. PubMed. 23(6 Suppl 16). 120–3. 5 indexed citations
7.
Weidmann, Eckhart, Jürgen Brieger, Bernhard Jahn, et al.. (1995). Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Annals of Hematology. 70(3). 153–158. 5 indexed citations
8.
Heil, Gerhard, P.S. Mitrou, D. Hoelzer, et al.. (1995). High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia Long-term follow-up of a prospective multicenter trial. Annals of Hematology. 71(5). 219–225. 1 indexed citations
9.
Bergmann, Lothar, T. Karakas, Elke Jäger, et al.. (1995). Vincristine, doxorabicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma — a multicenter phase II study. Annals of Oncology. 6(10). 1019–1024. 5 indexed citations
10.
Bergmann, Lars & P.S. Mitrou. (1994). Cytokines in cancer therapy. KARGER eBooks. 1 indexed citations
11.
12.
Kurrle, E., Gerhard Ehninger, M. Freund, et al.. (1990). Consolidation Therapy with High-Dose Cytosine Arabinoside: Experiences of a Prospective Study in Acute Myeloid Leukemia. Hämatologie und Bluttransfusion. 33. 254–260. 4 indexed citations
13.
Kurrle, E., Gerhard Ehninger, Mathias Freund, et al.. (1988). A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Annals of Hematology. 56(5). 233–236. 9 indexed citations
14.
Kurrle, E., Gerhard Ehninger, Mathias Freund, et al.. (1988). Induktions- und intensivierte Konsolidationstherapie der akuten myeloischen Leukämie des Erwachsenen. Oncology Research and Treatment. 11(1). 5–9. 1 indexed citations
15.
Kurrle, E., Gerhard Ehninger, Mathias Freund, et al.. (1986). Age Adapted Induction and Intensified Consolidation Therapy in Acute Myelogenous Leukemia. Oncology Research and Treatment. 9(3). 141–143. 3 indexed citations
16.
17.
Oka, Shiro, et al.. (1984). Aclacinomycin A. Cancer Treatment Reviews. 11(4). 299–302. 3 indexed citations
18.
Mitrou, P.S., et al.. (1978). Conversion of polycythemia vera to refractory anemia with hyperplastic bone marrow. Annals of Hematology. 36(1). 41–45. 1 indexed citations
19.
Mitrou, P.S., et al.. (1975). Some Aspects of Erythropoietic Cell Proliferation in Erythroleukaemia. Acta Haematologica. 53(2). 65–74. 5 indexed citations
20.
Mitrou, P.S., et al.. (1974). Unreifzellige Leukämien im Krankheitsverlauf des Morbus Hodgkin. DMW - Deutsche Medizinische Wochenschrift. 99(31). 1596–1597. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan R. Wiersma Breakdown of academic impact, for papers by Metter Ge Breakdown of academic impact, for papers by CM Niemeyer Breakdown of academic impact, for papers by Anna Grazia Recchia Breakdown of academic impact, for papers by D Hollard Breakdown of academic impact, for papers by Bloomfield Cd Breakdown of academic impact, for papers by R. Schlenk Breakdown of academic impact, for papers by Hai‐Rong Qiu Breakdown of academic impact, for papers by Laurence Detourmignies Breakdown of academic impact, for papers by Angeline Van Orshoven
Rankless by CCL
2026